Walt Linscott

Walt Linscott

Director/Board Member at MEDESIS PHARMA S.A.

Net worth: 95 790 $ as of 31/05/2026

66 year
Health Technology
Consumer Services
Commercial Services

Profile

Walt A. Linscott is currently a Member of the Supervisory Board at Medesis Pharma SA since 2022.
Former roles include Secretary & General Counsel at Solvay Pharmaceuticals, Inc. from 2001 to 2005; Associate & Partner at Thompson Hine LLP from 1990 to 2001 and again from 2005 to 2010; Secretary & General Counsel at Carestream Health, Inc. from 2011 to 2015; Secretary & General Counsel at Cocrystal Pharma, Inc. from 2015 to 2017; President, COO & General Counsel at Treiber Therapeutics, Inc. in 2017; Chief Business Officer at Intec Pharma Ltd. from 2018 to 2021; and Chief Operating Officer at Indaptus Therapeutics, Inc. from 2023 to 2026.
Education includes graduate degrees from the University of Oxford, the University of Cambridge, and the University of Dayton School of Law, and an undergraduate degree from Syracuse University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
21/01/2026 54,426 ( 0.05% ) 95 790 $ 31/05/2026

Walt Linscott active positions

CompaniesPositionStart
MEDESIS PHARMA S.A. Director/Board Member 27/10/2022

Former positions of Walt Linscott

CompaniesPositionEnd
INDAPTUS THERAPEUTICS, INC. Chief Operating Officer 01/06/2026
Chief Administrative Officer 01/07/2018
Treiber Therapeutics, Inc.
President 01/10/2017
COCRYSTAL PHARMA, INC. General Counsel 01/03/2017
General Counsel 01/01/2015
See the detail of Walt Linscott's experience

Training of Walt Linscott

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

38

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Treiber Therapeutics, Inc.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!